Structure via PubChem · Public domain (PubChem)
براپروست
Sign in to saveAlso known as MDL 201229, MDL-201229, ML 1229, ML-1229
Beraprost is a pharmaceutical drug used in several Asian countries, including Japan and South Korea, as a vasodilator and antiplatelet agent. It is classified as a prostacyclin analog.
Chemical data
- Formula
- C24H30O5
- Molecular weight
- 398.5 g/mol
- IUPAC name
- 4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoic acid
via PubChem
Research
575 papers- Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.Drugs · 2002
- Beraprost sodium ameliorates cognitive impairment by promoting oligodendrocyte precursor cell proliferation and differentiation in vascular cognitive impairment mouse model.Neuropharmacology · 2025
- The effects of beraprost sodium on renal function and cardiometabolic profile in patients with diabetes mellitus: a systematic review and meta-analysis of clinical trials.International urology and nephrology · 2022
- Beraprost and Overall Survival in Cats with Chronic Kidney Disease.Veterinary sciences · 2023
- Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination.Cell death & disease · 2021
via PubMed
Wikidata facts
- Subclass of
- unsaturated compound
- Mass
- 398.209324
Show 3 more facts
- chemical formula
- C₂₄H₃₀O₅
- canonical SMILES
- CC#CCC(C)C(C=CC1C(CC2C1C3=C(O2)C(=CC=C3)CCCC(=O)O)O)O
- subject has role
- platelet aggregation inhibitors
Sources (1)
via Wikidata · CC0
Available in 11 languages
via Wikidata sitelinks · CC0